MarketBeat provided a consensus rating for Quest Diagnostics, and Truist Financial raised its price target for the company.
4 reports, 1 independent
Updated Sep 23
Mostly repetition
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided a consensus rating for Quest Diagnostics, and Truist Financial raised its price target for the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Quest Diagnostics
medical research company
-
MarketBeat
American personal finance blog
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- MarketBeat reports consensus ratings and price targets for the company LandBridge.
- MarketBeat provided consensus price targets and ratings regarding a company involving Lazard on May 27, 2026.
- Truist Financial boosted its price objective on Carnival Corporation, with MarketBeat providing consensus ratings.
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- MarketBeat published consensus price targets and analyst recommendations concerning the Financial Services Industry on September 1, 2026.
Coverage
Newest first; wire copies grouped- dailypolitical.comTruist Financial Forecasts Strong Price Appreciation for Quest Diagnostics (NYSE:DGX) Stock